Jefferies Upgrades AdaptHealth to Buy, Raises Price Target to $13

Benzinga · 2d ago
Jefferies analyst Brian Tanquilut upgrades AdaptHealth (NASDAQ:AHCO) from Hold to Buy and raises the price target from $11 to $13.